Plain-language summary
Melasma is a common hyperpigmentation disorder that often resists treatment, because it is driven not by a single defect but by a whole pathological microenvironment: overactive melanocytes, abnormal blood vessel growth, oxidative stress and chronic inflammation. Therapies that hit only one of these drivers tend to give partial or short-lived responses. To tackle the condition more broadly, researchers designed a bioinspired, stimulus-responsive microneedle patch (TXA/Exo@HAMA-PBA) that co-delivers two agents. The needles copy the backward-curving barbs on a tick's mouthparts, helping the patch grip and stay anchored in skin. Exosomes from adipose-derived stem cells are chemically coupled into the hydrogel matrix through reactive-oxygen-species-sensitive boronate ester bonds, while tranexamic acid is physically encapsulated; the oxidative environment of the lesion then triggers release of both. The two act in a coordinated division of labour: the exosomes mainly scavenge reactive oxygen species, whereas tranexamic acid preferentially disrupts abnormal capillary networks. Together they suppress melanin synthesis through the MITF/TYRP1 cascade and steer macrophages from a pro-inflammatory M1 state toward a tissue-reparative M2 state. In a UV- and progesterone-induced mouse model, the platform visibly reduced pigmentation, with bulk RNA sequencing supporting multidimensional regulation of the microenvironment.
Key findings
- Melasma persists because it is sustained by a multi-component pathological microenvironment - melanocyte hyperactivity, abnormal vascular growth, oxidative stress and chronic inflammation - so single-target treatments tend to give incomplete or transient results.
- The microneedle platform (TXA/Exo@HAMA-PBA) uses tick-inspired outward-facing barbs to anchor in skin, and couples adipose-derived stem cell exosomes into the HAMA-PBA matrix through reactive-oxygen-species-sensitive boronate ester bonds while physically co-encapsulating tranexamic acid.
- The two payloads divide the work: the exosomes mainly scavenge local reactive oxygen species including hydroxyl radicals, whereas tranexamic acid preferentially disrupts abnormal capillary networks, jointly suppressing melanogenesis through the MITF/TYRP1 cascade.
- In a UV- and progesterone-induced mouse model of melasma, the system shifted macrophages from a pro-inflammatory M1 phenotype toward a tissue-reparative M2 phenotype, regulated the microenvironment at several levels, and produced visible depigmentation.
Original abstract
Clinically refractory melasma remains difficult to treat because it is driven by a multidimensional pathological microenvironment that includes melanocyte hyperactivity, aberrant vascular growth, oxidative stress and chronic inflammation. Single-pathway therapies therefore often produce incomplete or transient responses. To remodel this microenvironment more broadly, we developed a bioinspired, stimulus-responsive co-delivery microneedle platform (TXA/Exo@HAMA-PBA MNs). Inspired by the backward-curved barbs on the tick hypostome, the microneedles were engineered with outward-facing barbs to improve anchoring within skin tissue. Chemically, adipose-derived stem cell exosomes (ADSC-Exos) acted as bioactive crosslinking nodes. They were coupled to the HAMA-PBA matrix through ROS-sensitive dynamic boronate ester bonds, while tranexamic acid (TXA) was physically co-encapsulated. After insertion into ROS-rich melasma-like lesions, oxidative cleavage of carbon-boron bonds accelerated matrix degradation and promoted on-demand release of both payloads. Mechanistically, this platform produced an asymmetric but coordinated blockade of the pathological microenvironment: ADSC-Exos mainly scavenged local ROS, including ·OH, whereas TXA preferentially disrupted abnormal capillary networks. Together, they suppressed melanogenesis through the MITF/TYRP1 cascade and shifted macrophages from a pro-inflammatory M1 phenotype towards a tissue-reparative M2 phenotype. In a UV/progesterone-induced mouse model of melasma validated by bulk RNA sequencing, the system produced multidimensional microenvironmental regulation and visible depigmentation. This bioinspired, spatiotemporally responsive co-delivery microneedle platform integrates complementary and synergistic therapeutic actions and offers a translational strategy for complex, multifactorial hyperpigmentary disorders.
Frequently asked questions
What did this study find?
Melasma is a common hyperpigmentation disorder that often resists treatment, because it is driven not by a single defect but by a whole pathological microenvironment: overactive melanocytes, abnormal blood vessel growth, oxidative stress and chronic inflammation. Therapies that hit only one of these drivers tend to give partial or short-lived responses. To tackle the condition more broadly, researchers designed a bioinspired, stimulus-responsive microneedle patch (TXA/Exo@HAMA-PBA) that co-delivers two agents. The needles copy the backward-curving barbs on a tick's mouthparts, helping the patch grip and stay anchored in skin. Exosomes from adipose-derived stem cells are chemically coupled into the hydrogel matrix through reactive-oxygen-species-sensitive boronate ester bonds, while tranexamic acid is physically encapsulated; the oxidative environment of the lesion then triggers release of both. The two act in a coordinated division of labour: the exosomes mainly scavenge reactive oxygen species, whereas tranexamic acid preferentially disrupts abnormal capillary networks. Together they suppress melanin synthesis through the MITF/TYRP1 cascade and steer macrophages from a pro-inflammatory M1 state toward a tissue-reparative M2 state. In a UV- and progesterone-induced mouse model, the platform visibly reduced pigmentation, with bulk RNA sequencing supporting multidimensional regulation of the microenvironment.
Was this tested in humans or in the laboratory?
This is preclinical work — the findings come from laboratory models, not from human participants.
Where can I read the original paper?
The full text lives with the publisher: https://doi.org/10.1016/j.mtbio.2026.103496
How to cite this paper
Ding Hao, Zhang Erhao, Wang Yubin, Guo Chunyi, Sun Yixin, Zhang Xinyu et al.. Bionic intelligent responsive barbed microneedles synergistically remodel the microenvironment for the treatment of refractory pigmentation disorders (melasma).. Materials today. Bio. 2026, 2026-08-11. DOI: 10.1016/j.mtbio.2026.103496
Source & verification
- Journal: Materials today. Bio
- Published: 11 August 2026
- DOI: 10.1016/j.mtbio.2026.103496
- PubMed ID: 42577005
- Indexed via: pubmed
- MeSH terms: —